Rocket Pharmaceuticals Acquisition | Healthcare Deal in NJ

Rocket Pharmaceuticals has completed an other acquisition involving Rocket Pharmaceuticals, a pharmacy business in New Jersey, for $3.00. The company is exchanging eligible employee options to purchase Rocket Pharmaceuticals common stock, using replacement options tied to its healthcare operations. This pharmacy acquisition supports internal equity and compensation restructuring for employees in NJ, aligning option terms with corporate objectives. The healthcare M&A filing is an amendment to a Schedule TO under Rule 13e-4, reflecting results of the option exchange and remaining unchanged information from the April 27, 2026 tender offer statement.